As big pharmas and other commercial-stage biopharma and biotech companies grapple with the reality of patent cliffs on the horizon, which...
A Fresh Take
Insights on US legal developments
/Passle/5e8c58ad3dccd208784b45a3/MediaLibrary/Images/2024-10-15-19-53-27-360-670ec837dd71ccaa0996a993.png)
Antitrust enforcers in the second Trump administration have already shifted away from several hallmarks of Biden-era merger antitrust...
On August 18, 2025, the New York Law Journal published an article by Freshfields lawyers titled “Hyperlinked Documents: Modern...
After a temporary “pause” in enforcement of the Foreign Corrupt Practices Act (“FCPA”) and issuance of revised Guidelines for...
The Committee on Foreign Investment in the United States (“CFIUS”) recently released its calendar year 2024 annual report to Congress...
Executive Summary On August 7, 2025, President Trump signed an executive order, “Democratizing Access to Alternative Assets for 401(k)...
Over halfway through the first year of President Trump’s second term, the Administration has employed a range of legal and regulatory...
On August 6, 2025, the Federal Trade Commission (FTC) issued an administrative complaint, and a concurrent complaint in the U.S. District...
International banks recently won a significant legal battle that could reshape the scope of potential liability in terrorism-related...
On Thursday, August 7, 2025, President Trump issued a new Executive Order (EO), “Guaranteeing Fair Banking for All Americans,” that...
The original article was published in 13D Monitor’s The Activist Report – August Issue in August 2025. Leza Bieber is a corporate partner...
In a groundbreaking decision of particular importance to participants in Chapter 15 proceedings, the United States Court of Appeals for...